EGFR and non-small cell lung carcinoma: Using panels of predominantly EGFR-wild type NSCLC cell lines, several EGFR TKI response signatures were derived (Thomson et al., 2005; Yauch et al., 2005; Witta et al., 2006; Byers et al., 2013).